PD-L1 tumour cell expression (%) in lymph node metastases and skin metastases.

NIAID Data Ecosystem2026-05-02 收录

数据链接：

https://figshare.com/articles/dataset/PD-L1_tumour_cell_expression_in_lymph_node_metastases_and_skin_metastases_/28317380 数据链接链接失效反馈

官方服务：

资源简介：

PD-L1 tumour cell expression (%) in lymph node metastases and skin metastases.

创建时间：

2025-01-30

Supplementary Table S2 from Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer

结直肠癌基因组学

肿瘤免疫治疗生物标志物

Genomic alterations detected in plasma cfDNA and tumor tissue

NIAID Data Ecosystem40

Table_3_Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia.xlsx

血液肿瘤基因组学

肿瘤免疫治疗生物标志物

Acute myeloid leukemia (AML) is a heterogeneous disease related to a broad spectrum of molecular alterations. The successes of immunotherapies treating solid tumors and a deeper understanding of the i

NIAID Data Ecosystem20

Table 3_Baseline neuronal antibodies in patients with small cell lung cancer are not necessarily associated with post-immune checkpoint inhibitors neurotoxicities.docx

肿瘤免疫治疗生物标志物

神经毒性评估

Background and objectivesAutoantibodies against intracellular neuronal antigens (IC-Abs) can be found in neurologically asymptomatic patients with small cell lung cancer (SCLC) and have been proposed

NIAID Data Ecosystem00

Table1_Identification of the molecular characteristics associated with microsatellite status of colorectal cancer patients for the clinical application of immunotherapy.XLSX

肿瘤免疫治疗生物标志物

结直肠癌单细胞分析

Background: Mismatch repair-proficient (pMMR) microsatellite stability (MSS) in colorectal cancer (CRC) indicates an unfavorable therapeutic response to immunotherapy with immune checkpoint inhibitors

NIAID Data Ecosystem20

Table_2_Epigenetic-related gene mutations serve as potential biomarkers for immune checkpoint inhibitors in microsatellite-stable colorectal cancer.docx

肿瘤免疫治疗生物标志物

结直肠癌分子亚型

BackgroundCombination therapy with immune checkpoint inhibitors (ICIs) may benefit approximately 10-20% of microsatellite-stable colorectal cancer (MSS-CRC) patients. However, there is a lack of optim

NIAID Data Ecosystem20

PD-L1 tumour cell expression (%) in lymph node metastases and skin metastases.

资源简介：

相关数据集